Congratulations to Jim Gern, MD, for his recent award of approximately $12,000 from the Graduate School Fall Competition Program. His project, The Cholesterol-Lowering Drug, Simvastatin, Attenuates Rhinovirus-Induced IP-10 Release from Human Monocytic Cells,” will test the hypothesis that the cholesterol-lowering drug, simvastatin, alters the human monocytic cell immune response to human rhinovirus, a major cause of acute asthma exacerbations. These experiments will provide insight on potential therapeutic targets linking lipid metabolism and inflammation.